Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Gains from Investment Securities (2017 - 2025)

Dare Bioscience's Gains from Investment Securities history spans 10 years, with the latest figure at $400000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 33.33% year-over-year to $400000.0; the TTM value through Dec 2025 reached $833465.0, down 16.65%, while the annual FY2025 figure was $407534.0, N/A changed from the prior year.
  • Gains from Investment Securities reached $400000.0 in Q4 2025 per DARE's latest filing, down from $448000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.0 million in Q1 2022 to a low of -$1.1 million in Q2 2022.
  • Average Gains from Investment Securities over 5 years is $209841.5, with a median of $308533.0 recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: skyrocketed 356.44% in 2022, then plummeted 103.63% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $264247.0 in 2021, then skyrocketed by 156.44% to $677632.0 in 2022, then tumbled by 124.58% to -$166545.0 in 2023, then skyrocketed by 460.26% to $600000.0 in 2024, then tumbled by 33.33% to $400000.0 in 2025.
  • Per Business Quant, the three most recent readings for DARE's Gains from Investment Securities are $400000.0 (Q4 2025), $448000.0 (Q2 2025), and -$14535.0 (Q1 2025).